U.S. federal trademark · Serial No. 98824432
Pharmaceutical research and development; scientific research and development; medical research and development in the field of medical preparations; pharmaceutical research and analysis services using machine learning analytics for drug efficacy and safety; technical consultation services and product development for others in the fields of biotechnology and pharmaceuticals; pharmaceutical and scientific research and development relating to RNA targeting and assay development; platform as a service (PaaS) featuring computer software platforms for performing drug discovery and development and biotechnology research; pharmaceutical drug development services related to proteins, ribosomes, RNA, and DNA
Pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders; pharmaceutical preparations, namely, RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics; biopharmaceutical preparations and agents, namely, pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders, and RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.